Guardant’s test analyzes circulating tumor DNA that is then used to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from treatment with the Braftovi combo therapy ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

Major change to bowel cancer screening as thousands more to be tested - The NHS aims to detect thousands more bowel cancer ...

NHS bowel cancer tests will be fine-tuned to spot more tumours early as part of a faster diagnosis drive. It is another win ...

The new rules come into force in England next month ...

The reported increase of the early onset of multiple types of cancer (defined as a cancer diagnosis prior to 50 years of age) ...

It's the top cause of cancer death for men and women combined, a new study says.

Because of the rising rates of colorectal cancer among younger people, the U.S. Preventive Services Task Force advises ...

Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

Colorectal cancer is now the leading cause of cancer deaths among people under 50 in the US, a study in the Journal of the ...